TTM
$2.23B
YoY change
-39.2%
5Y CAGR
+19.3%
Peak year (2022)
$18.88B
Cumulative revenue
$50.30B
Revenue history chart for Moderna (MRNA) from 2016 to 2025
Latest: $1.94B
Revenue growth chart for Moderna (MRNA) from 2016 to 2025
Latest: -39.2%
Revenue history table for Moderna (MRNA) from 2016 to 2025
| 2025 | $1.94B | -39.2% | −$1.25B | ||
| 2024 | $3.20B | -53.3% | −$3.65B | ||
| 2023 | $6.85B | -63.7% | −$12.03B | ||
| 2022 | $18.88B | +6.4% | +$1.14B | ||
| 2021 | $17.74B | +2107.6% | +$16.93B | ||
| 2020 | $803.39M | +1234.3% | +$743.19M | ||
| 2019 | $60.21M | -55.4% | −$74.86M | ||
| 2018 | $135.07M | -34.4% | −$70.76M | ||
| 2017 | $205.82M | +89.9% | +$97.43M | ||
| 2016 | $108.40M | — | — |
- 2025$1.94B-39.2%
- 2024$3.20B-53.3%
- 2023$6.85B-63.7%
- 2022$18.88B+6.4%
- 2021$17.74B+2107.6%
- 2020$803.39M+1234.3%
- 2019$60.21M-55.4%
- 2018$135.07M-34.4%
- 2017$205.82M+89.9%
- 2016$108.40M—
Revenue values are taken from Moderna's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's current revenue (TTM) is $2.23B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual revenue for Moderna (MRNA) came in at $1.94B – plunged 39.2% year-over-year.
Over 2020–2025 (5 years), Moderna revenue expanded at a +19.3% compound annual rate, with mixed annual results across the window.
Moderna revenue plunged from $18.88B in 2022 to $1.94B in 2025, a 89.7% drawdown.
2022 marks the peak revenue at $18.88B, with the historical low of $60.21M recorded in 2019.
Moderna Revenue by Year
Moderna Revenue 2025: $1.94B
2025's revenue for Moderna came in at $1.94B, plunged 39.2% below 2024.
Moderna Revenue 2024: $3.20B
Moderna posted revenue of $3.20B in 2024, plunged 53.3% below 2023.
Moderna Revenue 2023: $6.85B
In 2023, Moderna reported revenue of $6.85B, plunged 63.7% below 2022.
Moderna Revenue 2022: $18.88B
Moderna revenue in 2022 was $18.88B, grew 6.4% from 2021. This figure represents the highest annual value in the available history.
Moderna Revenue 2021: $17.74B
Moderna revenue in 2021 was $17.74B.
See more financial history for Moderna (MRNA).
Sector peers by Revenue
Healthcare peers of Moderna (MRNA), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
Moderna (MRNA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation